3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
9
Genitourinary
5
Head & Neck
3
Gynecologic
3
Sarcoma
2
Dermatologic
2
Other neoplasm
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Cyclophosphamide
13
Peripheral Blood Stem Cell Transplantation
9
Biopsy
9
fludarabine phosphate
8
Busulfan
8
Whole-Body Irradiation
7
Surveys and Questionnaires
6
Mycophenolic Acid
6
Educational Status
6
Early Intervention, Educational
6
Carboplatin
6
fludarabine
5
Tacrolimus
5
Paclitaxel
5
Methotrexate
5
Methods
5
Melphalan
5
Epoetin Alfa
5
Decitabine
5
Cyclosporine
5
Colposcopy
5
Cisplatin
5
Celecoxib
5
Antilymphocyte Serum
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Radiotherapy
4
Patient Reported Outcome Measures
4
Magnetic Resonance Spectroscopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Transurethral Resection of Prostate
×
Other neoplasm
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled